Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06424015 · ClinicalTrials.gov registry record · NA

Insulin and Insulin Pulses During Fasting

A NA study of PreDiabetes, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06424015 is a NA study of PreDiabetes that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 60 participants, below the 690-participant average among 89 other PreDiabetes trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06424015, a NA study of PreDiabetes, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Fasting hyperglycemia contributes disproportionately to nonenzymatic glycosylation and the microvascular complications of type 2 diabetes. However, little is known about the regulation of glucose concentrations in the fasting state relative to what is known about the postprandial state. The proposed experiment is part of a series of experiments designed to establish how glucagon and insulin interact with their receptors to control fasting glucose in health and in prediabetes.

Conditions Studied

Interventions

  • OTHER Saline
  • OTHER Intralipid and heparin

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-09-15
Est. Completion 2027-09-01
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT06424015

The ClinicalTrials.gov registry entry for NCT06424015 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 690-participant average among 89 other PreDiabetes trials with a reported enrollment target (91% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with PreDiabetes appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.

NCT06424015 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06424015 about?

NCT06424015 is a clinical study titled "Insulin and Insulin Pulses During Fasting". Fasting hyperglycemia contributes disproportionately to nonenzymatic glycosylation and the microvascular complications of type 2 diabetes. However, little is known about the regulation of glucose concentrations in the fasting state relative to what is known about the postprandial state. The proposed...

What is the current status of trial NCT06424015?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-09-15. Estimated completion is 2027-09-01.

What conditions does trial NCT06424015 study?

This clinical trial studies the following conditions: PreDiabetes.

What interventions are being tested in trial NCT06424015?

The interventions under investigation include: Saline (OTHER), Intralipid and heparin (OTHER).

Who is sponsoring clinical trial NCT06424015?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06424015 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PreDiabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.